Day: October 22, 2024

Nokia CorporationStock Exchange Release22 October 2024 at 22:30 EET Nokia Corporation: Repurchase of own shares on 22.10.2024 Espoo, Finland – On 22 October 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 1,523,949 4.37CEUX 400,000 4.36BATE – –AQEU – –TQEX – –Total 1,923,949 4.37* Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program started on 20 March 2024. On 19 July 2024, Nokia decided to accelerate the share buybacks by...

Los Angeles, CA, Oct. 22, 2024 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, today announced its successful appeal to the NASDAQ Panel, and as a result the Company’s common stock will resume trading on the NASDAQ Capital Market Exchange at the open of trading on Wednesday, October 23, 2024. The Company was granted an extension until March 7, 2025, a 360-day grace period from the point at which the Market Value of Listed Securities (“MVLS”) requirement previously became non-compliant. BioSig’s CEO, Anthony Amato stated, “We’d like to thank Nasdaq and its leadership for their diligence and attention to detail working through the complexity of our case. We additionally...

Press release         Paris, October 22, 2024 iliad SA successfully issues inaugural €500 million green bond Financial release Today, iliad SA successfully placed a €500 million green bond issue. The bonds mature in just over five years, paying interest at 4.25% per year. This transaction, announced for a maximum amount of €500 million, met with very strong investor demand (with a final demand of over €1.5 billion), enabling the Group to take advantage of the improved market conditions and to refinance part of its existing bond debt via the tender offer launched in parallel for its bonds maturing in April 2025 and June 2026 (see previously published press release:https://www.iliad.fr/media/CP_211024_Eng_ef96e5d11f.pdf). This result confirms investors’ confidence in iliad’s creditworthiness and its ESG strategy. The proceeds...

WARREN, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, plans to provide further updates on the previously announced revenue forecast for Tevogen Oncology and Tevogen Specialty Care therapeutic areas by the end of this week. The revenue forecast for the two therapeutic areas is approximately $1 billion each in their respective launch years. The 5-year combined estimate for the two therapeutic areas is between $28 billion and $36 billion. Tevogen Bio also plans to update shareholders on Tevogen AI, its proprietary artificial intelligence effort, designed to advance a mission to lower the total cost of drug development,...

Reykjavik, Oct. 22, 2024 (GLOBE NEWSWIRE) — (“Amaroq” or the “Corporation” or the “Company”) Schedule 2(g) Disclosure TORONTO, ONTARIO – 22 October 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine development company with a substantial land package of gold and strategic mineral assets in Southern Greenland, announces the following information in relation to Schedule 2(g) of the AIM Rules, including additional details to those previously published in the Board changes announcement on 27 August 2021: Warwick Peter Morley-Jepson, non-executive director of Amaroq, has held the following directorships and/or partnerships that are disclosable in relation to Schedule 2(g) of the AIM Rules:Current Directorships Past DirectorshipsAmaroq Minerals Ltd Wesdome Gold Mines Limited  Karora Resources...

CEDAR RAPIDS, Iowa, Oct. 22, 2024 (GLOBE NEWSWIRE) — United Fire Group, Inc. (Nasdaq: UFCS) (the “Company”, “UFG”, “we”, or “our”) announced today that its 2024 third quarter earnings results will be released after the market closes on Tuesday, November 5, 2024. An earnings call will be held on Wednesday, November 6, 2024 at 9:00 a.m. central time to allow securities analysts, shareholders and other interested parties the opportunity to hear management discuss the Company’s 2024 third quarter results. Teleconference: Dial-in information for the call is toll-free 1-844-492-3723 (international 1-412-542-4184). Participants should request to join the United Fire Group call. The event will be archived and available for digital replay through November 13, 2024. The replay access...

Gen-3 Halo Headset Designed to Offer Convenient At-Home Treatment Through Virtual Clinic Model Study to Build on Positive Results from Previous Clinical Trial Treating Veterans with Mild Traumatic Brain Injury (mTBI) HOUSTON, TX, Oct. 22, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced plans to commence a new clinical trial in collaboration with the University of California, San Diego (UCSD). Dr Ming Xiong Huang, the UCSD principal investigator, will utilize his affiliation with the San Diego VA to recruit some of the patients for the study who have been victims of Traumatic Brain Injury (TBI). This trial will focus on the effectiveness of Nexalin’s next-generation Gen-3 Halo headset, designed to be used in a virtual clinic model, allowing patients to receive treatment...

Follow-up to the Paris Commercial Court hearing of October 18, 2024 Fleurieux-sur-l’Arbresle – France – October 22, 2024, 8.15 p.m. As part of the Paris Commercial Court’s hearing on October 18, 2024 to present the recovery plans for Safe SA and its subsidiaries (Safe Orthopaedics and Safe Medical), the Safe Group, which specializes in the design, manufacture and marketing of medical devices for spinal surgery, was notified of a favorable opinion by the procedural bodies, which will be the subject of deliberations starting on November 5. The Company will keep the market regularly informed of progress in the procedure. About Safe Group Safe Group is a French medical technology group that brings together Safe Orthopaedics, a pioneer in ready-to-use technologies for spine pathologies, and Safe Medical (formerly LCI Medical), a...

BATON ROUGE, La., Oct. 22, 2024 (GLOBE NEWSWIRE) — In the release issued under the same headline on Tuesday, October 22nd, by H&E Equipment Services, Inc. (NASDAQ: HEES) (“H&E”, the “Company”, d/b/a “H&E Rentals”), please note in the first sentence of the second paragraph, the date for the live broadcast should be October 29th, not July 30th. The corrected release follows: H&E Equipment Services, Inc. (NASDAQ: HEES) (“H&E”, the “Company”, d/b/a “H&E Rentals”) today announced that it will release its 2024 third quarter financial results before the market on Tuesday, October 29, 2024. The Company will also hold a conference call to discuss third quarter results on Tuesday, October 29, 2024, at 10:00 a.m. (Eastern Time). To listen to the call, participants should dial...